IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $170,570 | -31.6% | 37,488 | +5.8% | 0.00% | -100.0% |
Q2 2023 | $249,413 | -4.2% | 35,428 | -16.8% | 0.00% | 0.0% |
Q1 2023 | $260,219 | +6.4% | 42,589 | +6.4% | 0.00% | 0.0% |
Q4 2022 | $244,492 | +50.9% | 40,015 | +136.4% | 0.00% | 0.0% |
Q3 2022 | $162,000 | -6.9% | 16,925 | +7.3% | 0.00% | 0.0% |
Q2 2022 | $174,000 | -34.8% | 15,776 | -1.4% | 0.00% | 0.0% |
Q1 2022 | $267,000 | -7.3% | 16,007 | +6.0% | 0.00% | 0.0% |
Q4 2021 | $288,000 | -38.1% | 15,098 | -19.9% | 0.00% | -50.0% |
Q3 2021 | $465,000 | -5.3% | 18,851 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $491,000 | +51.5% | 18,851 | +84.1% | 0.00% | +50.0% |
Q1 2021 | $324,000 | +5.5% | 10,241 | +55.0% | 0.00% | 0.0% |
Q4 2020 | $307,000 | +72.5% | 6,608 | +21.9% | 0.00% | 0.0% |
Q3 2020 | $178,000 | +24.5% | 5,421 | +3.8% | 0.00% | 0.0% |
Q2 2020 | $143,000 | -37.8% | 5,222 | -32.1% | 0.00% | -50.0% |
Q1 2020 | $230,000 | +42.9% | 7,687 | +21.9% | 0.00% | +100.0% |
Q4 2019 | $161,000 | -0.6% | 6,307 | -29.0% | 0.00% | -33.3% |
Q3 2019 | $162,000 | -9.5% | 8,881 | +21.4% | 0.00% | 0.0% |
Q2 2019 | $179,000 | +17.0% | 7,317 | -54.6% | 0.00% | 0.0% |
Q1 2019 | $153,000 | +11.7% | 16,122 | +4.9% | 0.00% | 0.0% |
Q4 2018 | $137,000 | +31.7% | 15,374 | +66.9% | 0.00% | +50.0% |
Q3 2018 | $104,000 | – | 9,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |